Darin M. Lippoldt

Darin M. Lippoldt

Chief Legal OfficeratNeurocrine Biosciences· In proxies 2020–2022

Pay in FY2022-16% from the year before · Neurocrine Biosciences stock +40.2% the same year

Darin M. Lippoldt was paid $4.7M in FY2022 (Dec), down 16%. Neurocrine Biosciences stock rose 40.2% that year.

Pay$100 in the stock at the end of FY19 → $111
Pay is from the Summary Compensation Table of each Neurocrine Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Neurocrine BiosciencesPublic company · 6 yr
    • Chief Legal Officer2020 – Present · 6 yrStock in role +33%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?